$-0.12 EPS Expected for Canopy Growth Corporation (CGC)

August 9, 2018 - By Vernon Prom

Analysts expect Canopy Growth Corporation (NYSE:CGC) to report $-0.12 EPS on August, 14 before the open.They anticipate $0.07 EPS change or 140.00 % from last quarter’s $-0.05 EPS. After having $-0.10 EPS previously, Canopy Growth Corporation’s analysts see 20.00 % EPS growth. The stock increased 2.07% or $0.57 during the last trading session, reaching $28.12. About 1.58M shares traded. Canopy Growth Corporation (NYSE:CGC) has 0.00% since August 9, 2017 and is . It has underperformed by 12.57% the S&P500.

Canopy Growth Corporation, through its subsidiaries, produces and sells medical marijuana in Canada. The company has market cap of $6.17 billion. The firm offers dried, oil, and softgel cannabis products. It currently has negative earnings. Canopy Growth Corporation also sells its products through online.

More notable recent Canopy Growth Corporation (NYSE:CGC) news were published by: Seekingalpha.com which released: “Wait For A Catalyst In Canopy Growth – Cramer’s Lightning Round (8/7/18)” on August 08, 2018, also Fool.com with their article: “5 Biggest International Marijuana Markets — and the Stocks Best Positioned to Profit in Them” published on August 05, 2018, Fool.com published: “3 Big-Name Marijuana Stocks With Plunging Profit Projections” on July 18, 2018. More interesting news about Canopy Growth Corporation (NYSE:CGC) were released by: Fool.com and their article: “2 More US Marijuana Companies Plan to Go Public in Canada” published on July 29, 2018 as well as Fool.com‘s news article titled: “Molson Coors Has Found Its Marijuana Partner” with publication date: August 04, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.